EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Renal Dysfunction Complicating the Management of Hematologic Diseases

Sai Zhou iD, Jieni Yu, Weiying Feng iD, Wenzhen Ruan

European Journal of Haematology · 2026

DOI: 10.1111/ejh.70253 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift European Journal of Haematology, 2026. Verfasst von Sai Zhou und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Shaoxing People's Hospital, Shaoxing, People's Republic of China. Hauptthemen laut MEDLINE: Hematologic Diseases, Kidney Diseases. Die Arbeit nennt 61 Literaturangaben. Gefördert von: Jiebang Guashuai Project of Shaoxing People's Hospital, Zhejiang Provincial Traditional Chinese Medicine Science and Technology Planning Project, Shaoxing Municipal Health and Wellness Science and Technology Plan Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Renal dysfunction is common in patients with hematologic diseases and frequently emerges at diagnosis or during treatment. Acute kidney injury, chronic kidney disease, and glomerular involvement may arise from disease biology, antineoplastic therapy, infection, transplantation‐related injury, or cumulative supportive exposures. In clinical practice, impaired kidney function rarely represents an isolated comorbidity; rather, it modifies therapeutic feasibility, dose intensity, supportive management, and long‐term outcomes. Renal impairment affects delivery of conventional chemotherapy, targeted and immune‐based therapies, complicates antimicrobial selection during immunosuppression, and influences eligibility and risk stratification for hematopoietic stem cell transplantation (HSCT). Beyond its immediate consequences, renal dysfunction carries prognostic significance and may reshape therapeutic goals as renal reserve evolves. Considering renal dysfunction as a modifier of hematologic management, rather than solely as a renal endpoint, clarifies its role in treatment planning across the disease continuum.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hematologic DiseasesKidney DiseasesHumansDisease ManagementHematopoietic Stem Cell TransplantationPrognosis

Autor:innen und Institutionen

  • Department of Hematology, Shaoxing People's Hospital, Shaoxing, People's Republic of China.
  • School of Medicine, Shaoxing University, Shaoxing, People's Republic of China.

ORCID-Profile: Sai Zhou, Weiying Feng

Förderung

  • Jiebang Guashuai Project of Shaoxing People's Hospital
  • Zhejiang Provincial Traditional Chinese Medicine Science and Technology Planning Project
  • Shaoxing Municipal Health and Wellness Science and Technology Plan Project

Zitieren

APA

Zhou, S., Yu, J., Feng, W., & Ruan, W. (2026). Renal Dysfunction Complicating the Management of Hematologic Diseases. European Journal of Haematology. https://doi.org/10.1111/ejh.70253

Vancouver

Zhou S, Yu J, Feng W, Ruan W. Renal Dysfunction Complicating the Management of Hematologic Diseases. European Journal of Haematology. 2026. doi:10.1111/ejh.70253

BibTeX
@article{Zhou2026,
  author = {Zhou, Sai and Yu, Jieni and Feng, Weiying and Ruan, Wenzhen},
  title = {Renal Dysfunction Complicating the Management of Hematologic Diseases},
  journal = {European Journal of Haematology},
  year = {2026},
  doi = {10.1111/ejh.70253}
}
Kostenlos starten →